Dechra Pharmaceuticals Share Price (DPH)

689.00 -5.50 (-0.79%) delayed: 7:12PM BST
Bid price 689.00 Open price 693.00
Ask price 689.50 Prev close 689.00
High price 709.21 Spread 0.07%
Low price 689.00 Volume 46,145

Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.

Dechra Pharmaceuticals Share Price Chart

Advanced Charts >>

Register now for FREE Dechra Pharmaceuticals share price charts

Dechra Pharmaceuticals Share Price Information

Name Dechra Pharmaceuticals Epic DPH
Sector Pharmaceuticals & Biotechnology ISIN GB0009633180
Activites Dechra Pharmaceuticals plc is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. Index FTSE 250

Dechra Pharmaceuticals Key Numbers

Latest Share Price (p) 689.00 Net Gearing (%) 50.04
Market Capitalisation (£m) 608.51 Gross Gearing (%) 57.94
Shares in issue (m) 87.71 Debt Ratio 43.96
P/E Ratio 33.69 Debt-to-Equity Ratio 0.57
Total dividends per share (p) 14.00 Assets / Equity Ratio 2.38
Dividend Yield (%) 2.08 Price to book value 3.48
Dividend cover (x) 1.25 ROCE 0.05
Earning per share (p) 20.59 EPS Growth (%) 31.57
52 week high / low 755.00 / 655.00 DPS Growth (%) 14.10

Dechra Pharmaceuticals Director Deals

Dec.Date Type Director Pos No. of Shares
03/03/2014 EXR Ian Page CEO 78,656
03/03/2014 SEXR Ian Page CEO 37,080
03/12/2013 EXR Ian Page CEO 5,316
03/09/2013 BUY Julian Heslop NED 5,000
03/09/2013 BUY Ishbel Macpherson NED 2,861

More Dechra Pharmaceuticals Director Deals >>

Dechra Pharmaceuticals Company News

14:33 25/07/2014

Holding(s) in Company

/* */ RNS Number : 3872N Dechra Pharmaceuticals PLC 25 July 2014      TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to...

07:36 08/07/2014

Dechra in line

Dechra Pharmaceuticals said group revenue for the year to end-June was up by approximately 1.6% at constant currency compared to the prior year. · Positive momentum with improved revenue growth for H2 at 3.7%, compared to a decline of 0.7% in H1 (all at constant currency); · All EU...

07:28 08/07/2014

Dechra revenues up

Dechra Pharmaceuticals' group revenue for the year to the end of June rose by approximately 1.6% at constant currency from last year - around 2.3% at actual exchange rates. The group saw positive momentum with improved revenue growth for H2 at 3.7%, compared to a decline of 0.7% in H1 (all at...

More Dechra Pharmaceuticals Company News >>

Register now for FREE Dechra Pharmaceuticals company news

Dechra Pharmaceuticals Share Price Discussions

more than 1 year ago

A really dreary share (DPH)

A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p...

Register now for FREE Dechra Pharmaceuticals share price discussions